Roivant Sciences Ltd. (ROIV)
USD 10.19
(3.35%)
USD 10.19
(3.35%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -765.26 Million | -843.39 Million | -677.72 Million | -552.13 Million | -761.83 Million | -1.02 Billion |
| Net Income | 4.23 Billion | -1.11 Billion | -924.11 Million | -900.23 Million | -519.39 Million | -749.36 Million |
| Depreciation & Amortization | 22.03 Million | 18.85 Million | 5.93 Million | - | - | - |
| Deferred income taxes | - | -4.35 Million | -5.93 Million | - | - | - |
| Stock-based compensation | 199.62 Million | 217.78 Million | 564.95 Million | 84.95 Million | 122.57 Million | 58.86 Million |
| Change in working capital | 19.03 Million | 6.34 Million | 15.71 Million | 71.93 Million | 15.29 Million | 49.67 Million |
| Other non-cash items | 96.03 Million | 33.44 Million | -334.28 Million | 191.19 Million | -264.33 Million | -329.07 Million |
| Investing Cash Flow | 5.2 Billion | -44.26 Million | 303.29 Million | -31.7 Million | 1.69 Billion | -57.6 Million |
| Investments in PPE | -1.38 Million | -12.69 Million | -17.43 Million | -5.8 Million | -4.91 Million | -11.39 Million |
| Acquisitions | -36.98 Million | 107.85 Million | -39 Thousand | - | 1.77 Billion | -2.59 Million |
| Investment purchases | - | - | 39 Thousand | -28.25 Million | -68.37 Million | -43.61 Million |
| Sales/Maturities of investments | 5.23 Billion | - | 320.17 Million | - | 16.44 Million | 46.21 Million |
| Other Investing Activities | 5.24 Billion | -139.43 Million | 561 Thousand | 2.35 Million | -20.04 Million | -46.21 Million |
| Financing Cash Flow | 419.36 Million | 499.46 Million | 306.79 Million | 456.26 Million | 217.16 Million | 767.01 Million |
| Debt repayment | -30.7 Million | -127.5 Million | -21.59 Million | - | -32.06 Million | -9.7 Million |
| Dividends payments | -6 Million | - | - | - | - | - |
| Common Stock Repurchased | 951 Thousand | -10.88 Million | - | -113 Thousand | -1.18 Billion | -7.37 Million |
| Common Stock Issuance | 438.55 Million | 382.83 Million | 313.42 Million | 455.75 Million | 1.35 Billion | 598.85 Million |
| Other Financing Activities | -43.75 Million | -10.88 Million | 14.95 Million | 621 Thousand | 83.48 Million | 185.24 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 22.68 Million | 4.35 Million | 15.4 Million | 3.75 Million | 6.59 Million | 4.53 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -3.64 Million | 1.98 Million | 316 Thousand | 68.18 Million | 8.69 Million | 45.13 Million |
| Cash at beginning of period | 1.69 Billion | 2.07 Billion | 2.14 Billion | 2.26 Billion | 849.55 Million | -269.58 Million |
| Cash at end of period | 6.55 Billion | 1.69 Billion | 2.07 Billion | 2.14 Billion | 2.18 Billion | 849.55 Million |
| Capital Expenditure | -1.38 Million | -12.69 Million | -17.43 Million | -5.8 Million | -4.91 Million | -11.39 Million |
| Effect of forex changes on cash | 616 Thousand | 6.28 Million | - | - | - | 1.43 Billion |
| Net cash flow / Change in cash | 4.85 Billion | -381.91 Million | -67.64 Million | -127.57 Million | 1.33 Billion | 1.11 Billion |
| Free Cash Flow | -766.65 Million | -856.08 Million | -695.16 Million | -557.94 Million | -766.74 Million | -1.03 Billion |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -182.49 Million | 4.23 Billion | 5.07 Billion | -331.11 Million | -327.84 Million | -60.86 Million |
| Depreciation & Amortization | 5.22 Million | 22.03 Million | 5.38 Million | 5.58 Million | 5.83 Million | 5.95 Million |
| Deferred income taxes | 5.3 Billion | - | -5.41 Billion | 104.54 Million | 7.56 Million | -32.46 Million |
| Stock-based compensation | 46.72 Million | 199.62 Million | 54.32 Million | 49.31 Million | 49.26 Million | 25.27 Million |
| Change in working capital | 15.95 Million | 19.03 Million | 21.19 Million | 17.12 Million | -35.24 Million | 21.18 Million |
| Other non-cash items | 37.46 Million | 96.03 Million | 49.96 Million | -41.88 Million | 50.49 Million | -138.17 Million |
| Investing Cash Flow | 6.92 Million | 5.2 Billion | 5.23 Billion | -36.45 Million | 105 Thousand | 113.55 Million |
| Investments in PPE | -349 Thousand | -1.38 Million | -355 Thousand | -275 Thousand | -403 Thousand | -1.62 Million |
| Acquisitions | -804 Thousand | -36.98 Million | 5.23 Billion | -36.17 Million | - | 114.56 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 5.23 Billion | 5.23 Billion | - | - | - | - |
| Other Investing Activities | 8.08 Million | 5.24 Billion | 5.23 Billion | 3000.00 | 508 Thousand | 614 Thousand |
| Financing Cash Flow | -32.62 Million | 419.36 Million | 236.63 Million | 207.87 Million | 7.47 Million | 210.33 Million |
| Debt repayment | -7.66 Million | -30.7 Million | -7.66 Million | -7.57 Million | -7.8 Million | -8.03 Million |
| Dividends payments | -6 Million | -6 Million | - | -6 Million | -6 Million | - |
| Common Stock Repurchased | 222.22 Million | 951 Thousand | - | -215.52 Million | -5.74 Million | -1.43 Million |
| Common Stock Issuance | 3.65 Million | 438.55 Million | 238.73 Million | 221.52 Million | 21.02 Million | 219.8 Million |
| Other Financing Activities | -28.61 Million | -43.75 Million | 5.56 Million | 215.44 Million | 6 Million | -1.43 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 20.88 Million | 22.68 Million | -8.34 Million | -1.79 Million | 11.94 Million | -9.61 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -4.93 Million | -3.64 Million | 29.54 Million | 18.92 Million | -47.18 Million | 30.79 Million |
| Cash at beginning of period | 6.68 Billion | 1.69 Billion | 1.42 Billion | 1.44 Billion | 1.69 Billion | 1.54 Billion |
| Cash at end of period | 6.55 Billion | 6.55 Billion | 6.68 Billion | 1.42 Billion | 1.44 Billion | 1.69 Billion |
| Capital Expenditure | -349 Thousand | -1.38 Million | -355 Thousand | -275 Thousand | -403 Thousand | -1.62 Million |
| Effect of forex changes on cash | -855 Thousand | 616 Thousand | 3.04 Million | -1.45 Million | -117 Thousand | 6.28 Million |
| Net cash flow / Change in cash | -135 Million | 4.85 Billion | 5.26 Billion | -26.46 Million | -242.46 Million | 151.07 Million |
| Free Cash Flow | -108.8 Million | -766.65 Million | -210.8 Million | -196.7 Million | -250.33 Million | -180.71 Million |
1942
ORPB
EVGN
ACHR
3796
CACC